Collectively, our data expand the current knowledge on risk gene involvement (e.g., MAPT, MAPK8, and NFE2L2) and molecular pathways leading to the phenotypic changes associated with CBD and PSP. The gene discussed is MAPK8; the disease is supranuclear palsy, progressive, 1.